查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
聚乙二醇化蛋白質市場規模,份額和趨勢分析報告按蛋白質類型（腦脊液,干擾素）,應用（癌症,肝炎）,產品/服務（消耗品,服務）,用戶和細分市場預測2022-2030
市場調查報告書
商品編碼
1147620

聚乙二醇化蛋白質市場規模,份額和趨勢分析報告按蛋白質類型（腦脊液,干擾素）,應用（癌症,肝炎）,產品/服務（消耗品,服務）,用戶和細分市場預測2022-2030

PEGylated Proteins Market Size, Share & Trends Analysis Report By Protein Type (CSF, Interferons), By Application (Cancer, Hepatitis), By Product & Services (Consumables, Services), By End-user, And Segment Forecasts, 2022 - 2030
出版日期: | 出版商: Grand View Research | 英文 200 Pages | 商品交期: 2-10個工作天內

價格

聚乙二醇化蛋白質市場增長和趨勢

根據 Grand View Research, Inc. 的最新報告，到 2030 年，全球聚乙二醇化蛋白質市場規模預計將達到 30.6 億美元，預測期內的複合年增長率為 11.71%。聚乙二醇化是將聚乙二醇聚合物鏈共價和非共價連接到治療劑、藥物和囊泡等分子上的過程。聚乙二醇化化合物還提供有助於行業擴張的其他優勢，例如改進的抗蛋白水解、延長的半衰期、低毒性和低免疫原性。

另一方面，聚乙二醇化工藝成本上升和部分藥物專利到期預計將在一定程度上製約行業擴張。然而，與非蛋白質藥物相比，蛋白質藥物越來越受歡迎，聚乙二醇化提高了蛋白質穩定性和循環半衰期，推動了預測期內聚乙二醇化蛋白質行業的增長。預計癌症、腎病和類風濕性關節炎等慢性病發病率上升是工業擴張的主要驅動力。例如，IARC（國際癌症研究機構）估計2020 年全球將有 1030 萬癌症死亡和 1930 萬癌症新病例。

此外，在每年 2950 萬新病例中，預計到 2040 年將有 1640 萬人死於癌症相關原因。根據聯合國愛滋病毒/愛滋病聯合規劃署 (UNAIDS) 情況說明書“2021 年全球愛滋病毒和愛滋病統計數據”，到 2020 年，全球將有 3770 萬人被診斷為愛滋病毒陽性。因此，隨著全球慢性病和傳染病的負擔，對製造藥品的需求預計將增長。這將促進研究並促進行業發展。預計 COVID-19 將對該行業產生積極影響。

根據 2021 年 6 月發表的題為“聚乙二醇化納米顆粒白蛋白結合的甾體人參皂甘衍生物減輕 SARS-CoV-2 介導的過度炎症反應”的研究，SARS-CoV-2 ICU 患者發現聚乙二醇化納米顆粒白蛋白結合(PNAB)-steroidal ginsenoside 可以成功降低組蛋白 H4 和 NETosis 相關因子的血漿水平，並減少 SREBP2 介導的全身炎症。 PNAB 甾體人參皂甘藥物可能有助於治療嚴重 SARS-CoV-2 患者常見的凝血和細胞因子風暴症狀。因此，鑑於使用聚乙二醇化技術開展了大量研究活動，COVID-19 大流行對該行業產生了積極影響。

此外，製藥和生物技術公司加大對研發項目的投資也在推動該行業的擴張。例如，2022 年 3 月，Flow Eighteen38 的母公司 CRO FairJourneyBiologics S.A. 是一家蛋白質科學部門，旨在加強和加快抗體表徵和蛋白質純化項目，將擴大該部門的蛋白質生產以及物理和生物學表徵。它已宣布對評估能力和服務的 500 萬歐元（558 萬美元）投資。預計此類投資將補充整體市場增長。過去幾年也出現了明顯的行業整合趨勢，主要參與者建立戰略合作夥伴關係以支持研發項目。

例如，2022 年 2 月，Merck KGaA 收購了 Exelead，這是一家專注於聚乙二醇化藥物和結合基於脂質納米顆粒 (LNP) 的藥物輸送技術的複雜注射劑的生物製藥 CDMO。此外，2022 年 7 月，歐洲藥品管理局 (EMA) 人用藥品委員會 (CHMP) 批准了鹽酸多柔比星（Celdoxome 聚乙二醇化脂質體）用於晚期卵巢癌、轉移性乳腺癌、艾滋病相關卡波西肉瘤，推薦批准用於治療晚期多發性骨髓瘤。從而促進行業的發展。

聚乙二醇化蛋白質市場報告要點

由於越來越多地使用基於試劑盒的聚乙二醇化產品線，耗材產品和服務部分將在 2021 年佔據最大份額

2021年，集落刺激因子蛋白類細分市場佔比較大。集落刺激因子促進血細胞的發育並改善其功能，從而有助於在癌症治療期間增強人體的免疫力。

因此，集落刺激因子在腫瘤學中的廣泛使用將推動這一領域的增長。

由於全球癌症的高發以及多□治療癌症的利用，2021年癌症應用領域將佔據很大份額。

2021 年，製藥和生物技術最終用戶部分所佔份額最大

生物技術和製藥公司在聚乙二醇化蛋白質方面不斷增加的研發支出將進一步推動細分市場的增長

由於單克隆抗體、促紅細胞生成素和乾擾素等治療慢性疾病的生物製劑的大量使用、政府資金的增加、對研究活動的資助以及正在進行的聚乙二醇化蛋白質項目，2021 年北美成為

由於靶向疾病的增加和聚乙二醇化蛋白質的高采用率，預計亞太地區在預測期內將以最高的複合年增長率增長。

內容

第 1 章調查方法及範圍

  • 調查方法
  • 調查假設
  • 調查方法
  • 資訊採購
    • 購買的數據庫
    • GVR 內部數據庫
    • 次要資訊
    • 初步調查
  • 資訊或數據分析
    • 數據分析模型
  • 市場製定和驗證
  • 模型詳細資訊
    • 商品流分析
      • 方法 1：商品流方法
      • 方法 2：使用自下而上的方法按國家/地區進行市場預測
  • 全球市場：CAGR 計算
  • 二級資訊列表
  • 主要資訊列表
  • 目的

第 2 章執行摘要

  • 2021 年市場概況

第 3 章市場變量、趨勢和範圍

  • 市場細分和範圍
  • 市場動態
    • 市場促進因素分析
      • 蛋白質類藥物的採用率增加
      • 治療性蛋白質聚乙二醇化的好處
      • 生物製劑研發費用增加
    • 市場抑制因素分析
      • 聚乙二醇化生產過程的成本很高
      • 新型聚乙二醇化生物製品的專利到期
  • 2021 年滲透率和增長前景圖
  • COVID-19 影響分析
  • 聚乙二醇化蛋白質市場分析工具
    • SWOT 分析，按因素（政治和法律、經濟、技術）
    • 波特的五力分析

第 4 章產品和服務的業務分析

  • 聚乙二醇化蛋白質市場：產品和服務的變化分析
  • 消耗品
  • 服務

第5章蛋白質類業務分析

  • 聚乙二醇化蛋白質市場：蛋白質類型的變異分析
  • 集落刺激因子
  • 干擾素
  • 促紅細胞生成素
  • 重組因子 VII
  • 其他

第 6 章應用業務分析

  • 聚乙二醇化蛋白質市場：應用變化分析
  • 癌症
  • 自身免疫性疾病
  • 肝炎
  • 多發性硬化症
  • 血友病
  • 胃腸道疾病
  • 其他

第 7 章最終用戶業務分析

  • 聚乙二醇化蛋白質市場：最終用戶差異分析
  • 製藥和生物技術公司
  • 委託研究機構
  • 學術和研究機構

第 8 章區域業務分析

  • 聚乙二醇化蛋白質市場：區域差異分析
  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 意大利
    • 西班牙
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳大利亞
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東和非洲
    • 南非
    • 沙特阿拉伯
    • 阿拉伯聯合酋長國

第 9 章競爭格局

  • 戰略框架
  • 公司簡介
    • Thermo Fisher Scientific, Inc.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • ABCAM PLC
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • ENZON PHARMACEUTICALS, INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • MERCK KGAA
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • CELARES GMBH
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • PROFACGEN
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • CREATIVE PEGWORKS
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • NOF CORPORATION
      • 公司簡介
      • NOF 美國公司
      • 財務業績
      • 產品基準
      • 戰略舉措
    • AURIGENE PHARMACEUTICAL SERVICES LTD.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
    • LAYSAN BIO, INC.
      • 公司簡介
      • 財務業績
      • 產品基準
      • 戰略舉措
Product Code: GVR-4-68039-990-1

PEGylated Proteins Market Growth & Trends:

The global PEGylated proteins market size is expected to reach USD 3.06 billion by 2030, registering a CAGR of 11.71% over the forecast period, according to a new report by Grand View Research, Inc. PEGylation is the process of attaching polyethylene glycol polymer chains to molecules, such as therapeutics, medication, or vesicle, covalently & non-covalently. The industry is anticipated to grow significantly over the projected period, primarily as a result of the rising demand for PEGylation, an increase in the prevalence of chronic diseases, and the existence of potent new treatment candidates.PEGylated compounds also have certain additional benefits that contribute to the industry expansion, including increased proteolytic protection, a longer half-life, lower toxicity, and lower immunogenicity.

On the other hand, increased PEGylation process costs and the patent expiration of some medications are anticipated to restrain industry expansion to some extent. However, the growing preference for protein-based medications over non-protein-based drugs and the improvement of protein stability and circulation half-life by PEGylation is expected to propel the PEGylated protein industry growth in the forecast period. The rising incidence of chronic diseases like cancer, kidney disease, and rheumatoid arthritis is the main factor contributing to the industry's expansion. For instance, the IARC (International Agency for Research on Cancer) estimates that there were 10.3 million cancer deaths and 19.3 million new cases of cancer worldwide in 2020.

Furthermore, 16.4 million people are expected to die from cancer-related causes by 2040, out of an estimated 29.5 million new instances of the disease per year. In addition, 37.7 million people worldwide were diagnosed HIV positive in 2020, according to the Global HIV and AIDS Statistics 2021 fact sheet from the Joint United Nations Program on HIV/AIDS (UNAIDS). As a result, the demand for producing medicines is anticipated to rise along with the burden of chronic & infectious diseases across the globe. This will encourage research and propel the industry's growth. It is anticipated that COVID-19 had a positive effect on the industry.

According to a study titled "PEGylated nanoparticle albumin-bound steroidal ginsenoside derivatives alleviate SARS-CoV-2-mediated hyper-inflammatory responses," published in June 2021, in SARS-CoV-2 ICU patients, PEGylated Nanoparticle Albumin-Bound (PNAB)-steroidal Ginsenoside can successfully reduce plasma levels of histone H4 and NETosis-related factors and reduce SREBP2-mediated systemic inflammation. PNAB-steroidal ginsenoside drugs may help treat coagulation and cytokine storm symptoms that are common in severe SARS-CoV-2 patients. Therefore, the COVID-19 pandemic had a favorable impact on the industry given the considerable research activities conducted using PEGylation technology.

In addition, the industry expansion is being boosted by the rising investments made in R&D projects by pharmaceutical and biotechnology firms. For instance, in March 2022, CRO FairJourneyBiologics S.A., the parent company of Flow Eighteen38, a division of protein sciences, established to enhance and expedite antibody characterization as well as protein purification projects, announced an investment of EUR 5 million (USD 5.58 million) into the division's protein production and physical and biological characterization capabilities and services. Such investments are anticipated to supplement the overall market growth. In addition, there is a discernible trend toward industry consolidation over the past years, with key players forming strategic partnerships to support the R&D projects.

For instance, in February 2022, Merck KGaA acquired Exelead, a biopharmaceutical CDMO with a focus on PEGylated pharmaceuticals and intricate injectable formulations, incorporating Lipid Nanoparticle (LNP)-based drug delivery technology. Furthermore, in July 2022, the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP), Doxorubicin hydrochloride (Celdoxome pegylated liposomal) was recommended for approval for the cure of advanced ovarian cancer, metastatic breast cancer, AIDS-related Kaposi's sarcoma, and progressing multiple myeloma. Thus, propelling the industry's growth.

PEGylated Proteins Market Report Highlights:

  • The consumables product & service segment accounted for the largest share in 2021 due to the growing usage of kit-based PEGylation product lines
  • The colony-stimulating factor protein type segment held a larger share in 2021. Colony-stimulating chemicals speed up the development of blood cells and improve their functionality, therefore they help boost a person's immune system while they are receiving cancer treatment
  • Thus, extensive use of colony-stimulating factors in oncology will promote the growth of this segment
  • The cancer application segment held a larger share in 2021 due to the high incidence of cancer worldwide and the use of peptide therapy for cancer
  • The pharmaceutical & biotechnology companies end-user segment held the largest share in 2021
  • The rising R&D expenditure by biotechnology and pharmaceutical firms for PEGylated protein will further boost the segment growth
  • North America was the largest region in 2021 due to the high use of biological medications for the treatment of chronic diseases, such as monoclonal antibodies, erythropoietin, and interferon, as well as rising government funding, funding for research activities, and ongoing projects for PEGylated protein
  • Asia Pacific is expected to grow at the highest CAGRover the forecast period due to the rising prevalence of target diseases and high PEGylated protein adoption

Table of Contents

Chapter 1 Methodology And Scope

  • 1.1 Research Methodology
  • 1.2 Research Assumptions
    • 1.2.1 Estimates And Forecast Timeline
  • 1.3 Research Methodology
  • 1.4 Information Procurement
    • 1.4.1 Purchased Database
    • 1.4.2 Gvr's Internal Database
    • 1.4.3 Secondary Sources
    • 1.4.4 Primary Research
  • 1.5 Information Or Data Analysis
    • 1.5.1 Data Analysis Models
  • 1.6 Market Formulation & Validation
  • 1.7 Model Details
    • 1.7.1 Commodity Flow Analysis
      • 1.7.1.1 Approach 1: Commodity Flow Approach
      • 1.7.1.2 Approach 2: Country Wise Market Estimation Using Bottom Up Approach
  • 1.8 Global Market: CAGR Calculation
  • 1.9 List of Secondary Sources
  • 1.10 List of Primary Sources
  • 1.11 Objectives
    • 1.11.1 Objective 1:
    • 1.11.2 Objective 2:

Chapter 2 Executive Summary

  • 2.1 Market Snapshot, 2021

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Segmentation & Scope
  • 3.2 Market Dynamics
    • 3.2.1 Market Drivers Analysis
      • 3.2.1.1 Increasing Adoption Of Proteins Based Drugs
      • 3.2.1.2 Advantages Of Pegylation Of Therapeutic Proteins
      • 3.2.1.3 Increased Spending On R&D Of Biologics
    • 3.2.2 Market Restraint Analysis
      • 3.2.2.1 High cost of production process for PEGylation
      • 3.2.2.2 Patent expiration for novel PEGylated biologics
  • 3.3 Penetration and Growth Prospect Mapping, 2021
  • 3.4 COVID - 19 Impact Analysis
  • 3.5 PEGylated Proteins Market Analysis Tools
    • 3.5.1 Swot Analysis, By Factor (Political & Legal, Economic, And Technological)
    • 3.5.2 Porter's Five Forces Analysis

Chapter 4 Product & Services Business Analysis

  • 4.1 Pegylated Proteins Market: Product & Services Movement Analysis
  • 4.2 Consumables
    • 4.2.1 Global Pegylated Proteins Market For Consumables Estimates And Forecast, 2018 - 2030 (USD Million)
  • 4.3 Services
    • 4.3.1 Global Pegylated Proteins Market For Services Market Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 5 Protein Type Business Analysis

  • 5.1 PEGylated Proteins Market: Protein Type Movement Analysis
  • 5.2 Colony - stimulating factor
    • 5.2.1 Global Pegylated Proteins Market For Colony - Stimulating Factor Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.3 Interferons
    • 5.3.1 Global Pegylated Proteins Market For Interferons Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.4 Erythropoietin
    • 5.4.1 Global Pegylated Proteins Market For Erythropoietin Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.5 Recombinant Factor Vii
    • 5.5.1 Global Pegylated Proteins Market For Recombinant Factor Vii Estimates And Forecast, 2018 - 2030 (USD Million)
  • 5.6 Others
    • 5.6.1 Global Pegylated Proteins Market For Other Proteins Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 6 Application Business Analysis

  • 6.1 Pegylated Proteins Market: Application Movement Analysis
  • 6.2 Cancer
    • 6.2.1 Global Pegylated Proteins Market For Cancer Estimates And Forecast, 2018 - 2030
  • 6.3 Autoimmune Diseases
    • 6.3.1 Global Pegylated Proteins Market For Autoimmune Diseases Estimates And Forecast, 2018 - 2030
  • 6.4 Hepatitis
    • 6.4.1 Global Pegylated Proteins Market For Hepatitis Estimates And Forecast, 2018 - 2030
  • 6.5 Multiple Sclerosis
    • 6.5.1 Global Pegylated Proteins Market For Multiple Sclerosis Estimates And Forecast, 2018 - 2030
  • 6.6 Hemophilia
    • 6.6.1 Global Pegylated Proteins Market For Hemophilia Estimates And Forecast, 2018 - 2030
  • 6.7 Gastrointestinal Disorders
    • 6.7.1 Global Pegylated Proteins Market For Gastrointestinal Disorders Estimates And Forecast, 2018 - 2030
  • 6.8 Others
    • 6.8.1 Global Pegylated Proteins Market For Other Applications Estimates And Forecast, 2018 - 2030

Chapter 7 End - user Business Analysis

  • 7.1 PEGylated Proteins Market: End - user Movement Analysis
  • 7.2 Pharmaceutical & Biotechnology Companies
    • 7.2.1 Global Pegylated Proteins Market For Pharmaceutical & Biotechnology Companies Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.3 Contract Research Organizations
    • 7.3.1 Global Pegylated Proteins Market For Contract Research Organizations Estimates And Forecast, 2018 - 2030 (USD Million)
  • 7.4 Academic & Research Institutes
    • 7.4.1 Global Pegylated Proteins Market For Academic & Research Institutes Estimates And Forecast, 2018 - 2030 (USD Million)

Chapter 8 Regional Business Analysis

  • 8.1 PEGylated Proteins Market: Regional Movement Analysis
  • 8.2 North America
    • 8.2.1 North America Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.2 U.S.
      • 8.2.2.1 U.S. Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.2.3 Canada
      • 8.2.3.1 Canada Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.3 Europe
    • 8.3.1 Europe Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.2 Germany
      • 8.3.2.1 Germany Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.3 France
      • 8.3.3.1 France Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.4 U.K.
      • 8.3.4.1 U.K. Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.5 Italy
      • 8.3.5.1 Italy Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.3.6 Spain
      • 8.3.6.1 Spain Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.4 Asia - Pacific
    • 8.4.1 Asia - Pacific Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.2 Japan
      • 8.4.2.1 Japan Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.3 China
      • 8.4.3.1 China Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.4 India
      • 8.4.4.1 India Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.5 Australia
      • 8.4.5.1 Australia Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.4.6 South Korea
      • 8.4.6.1 South Korea Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.5 Latin America
    • 8.5.1 Latin America Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.2 Brazil
      • 8.5.2.1 Brazil Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.3 Mexico
      • 8.5.3.1 Mexico Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.5.4 Argentina
      • 8.5.4.1 Argentina Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
  • 8.6 Middle East And Africa
    • 8.6.1 Middle - East And Africa Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.2 South Africa
      • 8.6.2.1 South Africa Pegylated Proteins Market Estimates And Forecast, 2018 - 2030 (USD Million)
    • 8.6.3 Saudi Arabia
      • 8.6.3.1 Saudi Arabia PEGylated Proteins market estimates and forecast, 2018 - 2030 (USD Million)
    • 8.6.4 UAE
      • 8.6.4.1 UAE PEGylated Proteins market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 9 COMPETITIVE LANDSCAPE

  • 9.1 Strategy Framework
  • 9.2 Company Profiles
    • 9.2.1 THERMO FISHER SCIENTIFIC, INC.
      • 9.2.1.1 Company overview
      • 9.2.1.2 Financial performance
      • 9.2.1.3 Product benchmarking
      • 9.2.1.4 Strategic initiatives
    • 9.2.2 ABCAM PLC
      • 9.2.2.1 Company overview
      • 9.2.2.2 Financial performance
      • 9.2.2.3 Product benchmarking
      • 9.2.2.4 Strategic initiatives
    • 9.2.3 ENZON PHARMACEUTICALS, INC.
      • 9.2.3.1 Company overview
      • 9.2.3.2 Financial performance
      • 9.2.3.3 Product benchmarking
      • 9.2.3.4 Strategic initiatives
    • 9.2.4 MERCK KGAA
      • 9.2.4.1 Company overview
      • 9.2.4.2 Financial performance
      • 9.2.4.3 Product benchmarking
      • 9.2.4.4 Strategic initiatives
    • 9.2.5 CELARES GMBH
      • 9.2.5.1 Company overview
      • 9.2.5.2 Financial performance
      • 9.2.5.3 Product benchmarking
      • 9.2.5.4 Strategic initiatives
    • 9.2.6 PROFACGEN
      • 9.2.6.1 Company overview
      • 9.2.6.2 Financial performance
      • 9.2.6.3 Product benchmarking
      • 9.2.6.4 Strategic initiatives
    • 9.2.7 CREATIVE PEGWORKS
      • 9.2.7.1 Company overview
      • 9.2.7.2 Financial performance
      • 9.2.7.3 Product benchmarking
      • 9.2.7.4 Strategic initiatives
    • 9.2.8 NOF CORPORATION
      • 9.2.8.1 Company overview
      • 9.2.8.1.1 NOF AMERICA CORPORATION
      • 9.2.8.2 Financial performance
      • 9.2.8.3 Product benchmarking
      • 9.2.8.4 Strategic initiatives
    • 9.2.9 AURIGENE PHARMACEUTICAL SERVICES LTD.
      • 9.2.9.1 Company overview
      • 9.2.9.2 Financial performance
      • 9.2.9.3 Product benchmarking
      • 9.2.9.4 Strategic initiatives
    • 9.2.10 LAYSAN BIO, INC.
      • 9.2.10.1 Company overview
      • 9.2.10.2 Financial performance
      • 9.2.10.3 Product benchmarking
      • 9.2.10.4 Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 4 Global PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 5 Global PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 6 Global PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 7 Global PEGylated Proteins Market, by Region, 2018 - 2030 (USD Million)
  • Table 8 North America PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
  • Table 9 North America PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 10 North America PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 11 North America PEGylated Proteins Market, Application, 2018 - 2030 (USD Million)
  • Table 12 North America PEGylated Proteins Market, End - user, 2018 - 2030 (USD Million)
  • Table 13 U.S. PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 14 U.S. PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 15 U.S. PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 16 U.S. PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 17 Canada PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 18 Canada PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 19 Canada PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 20 Canada PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 21 Europe PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
  • Table 22 Europe PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 23 Europe PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 24 Europe PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 25 Europe PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 26 Germany PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 27 Germany PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 28 Germany PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 29 Germany PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 30 U.K. PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 31 U.K. PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 32 U.K. PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 33 U.K. PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 34 France PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 35 France PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 36 France PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 37 France PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 38 Italy PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 39 Italy PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 40 Italy PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 41 Italy PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 42 Spain PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 43 Spain PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 44 Spain PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 45 Spain PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 46 Asia Pacific PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 51 China PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 52 China PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 53 China PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 54 China PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 55 Japan PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 56 Japan PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 57 Japan PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 58 Japan PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 59 India PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 60 India PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 61 India PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 62 India PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 63 South Korea PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 64 South Korea PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 65 South Korea PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 66 South Korea PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 67 Australia PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 68 Australia PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 69 Australia PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 70 Australia PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 71 Latin America PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
  • Table 72 Latin America PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 73 Latin America PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 74 Latin America PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 75 Latin America PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 76 Brazil PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 77 Brazil PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 78 Brazil PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 79 Brazil PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 80 Mexico PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 81 Mexico PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 82 Mexico PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 83 Mexico PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 84 Argentina PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 85 Argentina PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 86 Argentina PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 87 Argentina PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 88 Middle East & Africa PEGylated Proteins Market, by Country, 2018 - 2030 (USD Million)
  • Table 89 Middle East & Africa PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 90 Middle East & Africa PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 91 Middle East & Africa PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 92 Middle East & Africa PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 93 South Africa PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 94 South Africa PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 95 South Africa PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 96 South Africa PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 97 Saudi Arabia PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 98 Saudi Arabia PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 99 Saudi Arabia PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 100 Saudi Arabia PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)
  • Table 101 UAE PEGylated Proteins Market, by Product & Services, 2018 - 2030 (USD Million)
  • Table 102 UAE PEGylated Proteins Market, by Protein Type, 2018 - 2030 (USD Million)
  • Table 103 UAE PEGylated Proteins Market, by Application, 2018 - 2030 (USD Million)
  • Table 104 UAE PEGylated Proteins Market, by End - user, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Information Procurement
  • Fig. 3 Primary Research Pattern
  • Fig. 4 Market Research Approaches
  • Fig. 5 Value Chain - Based Sizing & Forecasting
  • Fig. 6 Market Formulation & Validation
  • Fig. 7 PEGylated Proteins, Market Segmentation
  • Fig. 8 Market Snapshot, 2021
  • Fig. 9 Market Trends & Outlook
  • Fig. 10 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 11 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 12 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 13 Porter's Five Forces Analysis
  • Fig. 14 Market Penetration Vs Growth Prospect Mapping, 2021
  • Fig. 15 Global PEGylated Proteins Market, Product & Services Outlook: Key Takeaways
  • Fig. 16 Global PEGylated Proteins Market: Product & Services Movement Analysis
  • Fig. 17 Global PEGylated Proteins Market, for Consumables, 2018 - 2030 (USD Million)
  • Fig. 18 Global PEGylated Proteins Market, for Services, 2018 - 2030 (USD Million)
  • Fig. 19 Global PEGylated Proteins Market, Protein Type Outlook: Key Takeaways
  • Fig. 20 Global PEGylated Proteins Market: Protein Type Movement Analysis
  • Fig. 21 Global PEGylated Proteins Market, for Colony - stimulating factor, 2018 - 2030 (USD Million)
  • Fig. 22 Global PEGylated Proteins Market, for Interferons, 2018 - 2030 (USD Million)
  • Fig. 23 Global PEGylated Proteins Market, for Erythropoietin, 2018 - 2030 (USD Million)
  • Fig. 24 Global PEGylated Proteins Market, for Recombinant factor VII, 2018 - 2030 (USD Million)
  • Fig. 25 Global PEGylated Proteins Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 26 Global PEGylated Proteins Market, Application Outlook: Key Takeaways
  • Fig. 27 Global PEGylated Proteins Market: Application Movement Analysis
  • Fig. 28 Global PEGylated Proteins Market, for Cancer, 2018 - 2030 (USD Million)
  • Fig. 29 Global PEGylated Proteins Market, for Autoimmune diseases, 2018 - 2030 (USD Million)
  • Fig. 30 Global PEGylated Proteins Market, for Hepatitis, 2018 - 2030 (USD Million)
  • Fig. 31 Global PEGylated Proteins Market, for Multiple sclerosis, 2018 - 2030 (USD Million)
  • Fig. 32 Global PEGylated Proteins Market, for Hemophilia, 2018 - 2030 (USD Million)
  • Fig. 33 Global PEGylated Proteins Market, for Gastrointestinal disorders, 2018 - 2030 (USD Million)
  • Fig. 34 Global PEGylated Proteins Market, for Others, 2018 - 2030 (USD Million)
  • Fig. 35 Global PEGylated Proteins Market, End - user Outlook: Key Takeaways
  • Fig. 36 Global PEGylated Proteins Market: End - user Movement Analysis
  • Fig. 37 Global PEGylated Proteins Market, for Pharmaceutical & biotechnology companies, 2018 - 2030 (USD Million)
  • Fig. 38 Global PEGylated Proteins Market, for Contract research organizations, 2018 - 2030 (USD Million)
  • Fig. 39 Global PEGylated Proteins Market, for Academic & research institutes, 2018 - 2030 (USD Million)
  • Fig. 40 Regional Marketplace: Key Takeaways
  • Fig. 41 Global PEGylated Proteins Market: Regional Movement Analysis
  • Fig. 42 North America PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 43 U.S. PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 44 Canada PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 45 Europe PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 46 Germany PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 47 U.K. PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 48 France PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 49 Italy PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 50 Spain PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 51 Asia Pacific PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 52 Japan PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 53 China PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 54 India PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 55 Australia PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia PEGylated Proteins Market, 2018 - 2030 (USD Million)
  • Fig. 64 UAE PEGylated Proteins Market, 2018 - 2030 (USD Million)